Contact us at (866) 265-5575 or sales@realhealthdata.com

ISPOR – Utilization Patterns of the First US Biosimilar, Filgrastim-Sndz

ISPOR – Utilization Patterns of the First US Biosimilar, Filgrastim-Sndz

Utilization Patterns of the First US Biosimilar, Filgrastim-Sndz

Karen E. Smoyer1, Bríain Ó Hartaigh2

1Curo, a Division of Envision Pharma Group, Philadelphia, PA, USA;
2Curo, a Division of Envision Pharma Group, Southport, CT, USA

 

> Download as a PDF

0 Comments

Leave a reply